Overview

Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis

Status:
Terminated

Trial end date:
2002-06-24

Target enrollment:

Participant gender:

Summary

The primary objective of this study was to determine the efficacy of etanercept plus methotrexate vs methotrexate alone in pediatric patients with active polyarticular course juvenile rheumatoid arthritis (JRA).

Phase:

Phase 3

Details

Lead Sponsor:

Amgen

Treatments:

Etanercept
Methotrexate